Occudo Quantitative Strategies LP Kezar Life Sciences, Inc. Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.6 - $0.92 $11,773 - $18,052	-19,622 Reduced 61.76%	12,147 $7,000
Q1 2024 May 15, 2024	SELL	$0.8 - $1.05 $2,020 - $2,651	-2,525 Reduced 7.36%	31,769 $28,000
Q3 2023 Nov 14, 2023	SELL	$1.08 - $2.54 $42,270 - $99,413	-39,139 Reduced 53.3%	34,294 $40,000
Q2 2023 Aug 14, 2023	BUY	$2.31 - $3.06 $112,307 - $148,771	48,618 Added 195.92%	73,433 $179,000
Q1 2023 May 15, 2023	BUY	$3.13 - $7.31 $77,670 - $181,397	24,815 New	24,815 $77,000
Q2 2022 Aug 15, 2022	BUY	$4.58 - $17.13 $430,803 - $1.61 Million	94,062 New	94,062 $778,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $430M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.